SV

Shaila Viren Merchant

Active Director Managing Director DIN 01789821
DIN 01789821 First appointment Oct 1988 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 14 active board seats
Past companies 12 historical roles
Total affiliations 26 Since Oct 1988
Shareholding value •••• Premium profile

About Shaila Viren Merchant

Data last updated:

Shaila Viren Merchant is a Managing Director at Encore Healthcare Private Limited (since 2013), Director at Gulf Enterprises Exports Private Limited (since 2019) and Director at Gulf Impex Private Limited (since 2014), and holds 11 more current directorships. The companies operate in Pharma, Professional Services and Trading. The 12 current companies with reported revenue have a combined latest revenue of ₹137 Cr; the largest is Encore Healthcare Private Limited at ₹128 Cr (FY 2025). Earlier, Shaila Viren Merchant was a Director at Vishwa Exim Private Limited (2014–2020) and Managing Director at Zyg Pharma Private Limited (2009–2015) and 10 more.

DIN 01789821
Primary Designation Managing Director
Industry Pharma
First Appointment 12 Oct 1988
Oldest Company Age 46 yrs
Largest company Encore Healthcare Private Limited · ₹128 Cr (FY 2025)
Combined revenue ₹137 Cr across 12 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Encore Healthcare Private Limited U85110MH2002PTC134732
Managing Director11 Dec 20132002₹128 Cr (FY 2025)Active
Director19 Mar 20191980₹2.28 Cr (FY 2024)Active
Gulf Impex Private Limited U51900MH2008PTC184499
Director16 Dec 20142008₹2.17 Cr (FY 2025)Active
Grk Exim Private Limited U51109MH2008PTC179832
Director16 Dec 20142008₹2.10 Cr (FY 2025)Active
Swastik Exim Private Limited U51109MH2010PTC199241
Director02 Mar 20202010₹71.7 Lakh (FY 2025)Active
Haveli Traders Private Limited U51109MH2008PTC179887
Director07 Sep 20202008₹61.1 Lakh (FY 2025)Active
Atharva Impex Private Limited U51909MH2010PTC199566
Director07 Sep 20202010₹29.5 Lakh (FY 2024)Active
Test Consultants Private Limited U24100MH1989PTC054092
Director07 Sep 20201989₹25.3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vishwa Exim Private Limited U51109MH2008PTC186350
Director17 Dec 20142008₹29,828 (FY 2021)Active
Zyg Pharma Private Limited U24230GJ1987PTC085170
Managing Director01 Apr 20091987Amalgamated
Unnati Exim Private Limited U78100MH2008PTC186110
Director17 Dec 20142008₹44.8 Lakh (FY 2025)Active
Gulf Exim Private Limited U51900MH2008PTC184936
Additional Director17 Dec 20142008Active
Neivadya Exim Private Limited U51109MH2008PTC186356
Director17 Dec 20142008₹18,028 (FY 2021)Strike Off
Director12 Oct 19881981₹55.7 Lakh (FY 2019)Amalgamated
Basil Growth Exim Private Limited U51909MH2008PTC181304
Director17 Dec 20142008₹29,828 (FY 2021)Strike Off
Halcyon Labs Private Limited U24230MH1984PTC033021
Director31 Jul 19981984₹52.86 Cr (FY 2024)Active
Designated Partner12 Feb 20202020Strike Off
Director16 Dec 20142008₹29,828 (FY 2021)Strike Off
Golden Arch Impx Private Limited U51900MH2008PTC184480
Director17 Dec 20142008₹29,828 (FY 2021)Strike Off
Modhi Exports Private Limited U51909MH2008PTC183194
Director16 Dec 20142008₹18,028 (FY 2021)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
R. C. Khimji Enterprises Llp
Encore Ventures Llp
Test Consultants Private Limited
Grk Exim Private Limited
Premium access

Shareholding and investment profile for Shaila Viren Merchant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shaila Viren Merchant

Shaila Viren Merchant currently holds 14 directorships: Encore Healthcare Private Limited (Managing Director, since 11 Dec 2013, revenue ₹128 Cr (FY 2025)); Gulf Enterprises Exports Private Limited (Director, since 19 Mar 2019, revenue ₹2.28 Cr (FY 2024)); Gulf Impex Private Limited (Director, since 16 Dec 2014, revenue ₹2.17 Cr (FY 2025)); Grk Exim Private Limited (Director, since 16 Dec 2014, revenue ₹2.10 Cr (FY 2025)); Swastik Exim Private Limited (Director, since 02 Mar 2020, revenue ₹71.7 Lakh (FY 2025)); and 9 more.

Shaila Viren Merchant was first appointed on 12 Oct 1988 as Director at Saidarshan Business Centres Private Limited. The most recent appointment on record is 07 Sep 2020 at Test Consultants Private Limited.

The 12 current companies of Shaila Viren Merchant that report revenue have a combined latest revenue of ₹137 Cr: Encore Healthcare Private Limited ₹128 Cr (FY 2025); Gulf Enterprises Exports Private Limited ₹2.28 Cr (FY 2024); Gulf Impex Private Limited ₹2.17 Cr (FY 2025); Grk Exim Private Limited ₹2.10 Cr (FY 2025); Swastik Exim Private Limited ₹71.7 Lakh (FY 2025); and 7 more.

Shaila Viren Merchant held 12 earlier board appointments: Vishwa Exim Private Limited (Director, 17 Dec 2014 to 31 Aug 2020); Zyg Pharma Private Limited (Managing Director, 01 Apr 2009 to 17 Jul 2015); Unnati Exim Private Limited (Director, 17 Dec 2014 to 31 Aug 2020); Gulf Exim Private Limited (Additional Director, 17 Dec 2014 to 21 Jul 2015); Neivadya Exim Private Limited (Director, 17 Dec 2014 to 31 Aug 2020); and 7 more.

The current boards of Shaila Viren Merchant's companies include Aman Suketu Majithia (Encore Healthcare Private Limited), Anjali Viren Merchant (Encore Healthcare Private Limited), Radhika Viren Merchant (Encore Healthcare Private Limited), Viren Ajitkumar Merchant (Encore Healthcare Private Limited), Devaki Gulabsi Khimji (Gulf Enterprises Exports Private Limited), Devyani Gulabsi Khimji (Gulf Enterprises Exports Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available